Comparação entre citrato trissódico e heparina como solução para selo de cateter em pacientes em hemodiálise

Bevilacqua, José Luís; Gomes, Jaelson Guilhem; Santos, Vanderson Farley Brito; Canziani, María Eugênia Fernandes

doi:10.1590/s0101-28002011000100012

Cited by 7 publications

(7 citation statements)

References 21 publications

(18 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Similar to the fi ndings of Bevilacqua et al 27 , we observed that Gram-negative bacteria were predominant among the isolates. The infections caused by non-fermenting Gram-negative bacilli, such as Acinetobacter baumannii, Pseudomonas aeruginosa, Chryseobacterium indologenes, and Stenotrophomonas maltophilia, are difficult to treat because they are highly resistant, can cause outbreaks of nosocomial infection, and are often associated with high mortality rates 28,29 .…”

Section: Discussionsupporting

confidence: 91%

“…In conclusion, it is important to identify which pathogens cause BSIs among patients in hemodialysis units because this information will guide initial therapy 27 . Surveillance studies by multidisciplinary teams are necessary so that appropriate measures can be implemented to prevent bacteremia and other complications associated with infection in patients with ESRD.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Bloodstream infection in patients with end-stage renal disease in a teaching hospital in central-western Brazil

Gauna

Oshiro

Luzio

et al. 2013

Rev. Soc. Bras. Med. Trop.

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 99%

Bloodstream infection in patients with end-stage renal disease in a teaching hospital in central-western Brazil

Gauna

Oshiro

Luzio

et al. 2013

Rev. Soc. Bras. Med. Trop.

View full text Add to dashboard Cite

“…Bevilacqua et al 30 e Bleyer³¹ afirmam que o uso de selos com diversos antibióticos e outras substâncias a exemplo do citrato vêm sendo testadas e comprovadas a sua eficácia na prevenção das infecções quando comparados ao uso da heparina, porém, seu uso deve ser avaliado de forma individual, garantindo menores prejuízos ao paciente.…”

Section: Resultsunclassified

Segurança do paciente em tratamento dialítico

Lemos

Batalha²

2018

View full text Add to dashboard Cite

O estudo teve como objetivo analisar a produção científica com a temática segurança do paciente em tratamento dialítico; levantar os principais eventos que comprometem a segurança do paciente nesse tratamento; e identificar ações de segurança desenvolvidas pelos serviços de saúde. Trata-se de uma revisão integrativa cuja coleta de dados ocorreu na base de dados Biblioteca Virtual em Saúde. Foram incluídos na revisão 14 artigos. Foi observada escassez da produção científica acerca do tema. Através das semelhanças no conteúdo dos artigos, emergiram 4 categorias: Implementação de ações para segurança do paciente em diálise, Clima/Cultura de segurança em pacientes em diálise, Conhecimento dos profissionais de saúde sobre segurança do paciente em diálise e Incidentes/Eventos Adversos em diálise. Os eventos adversos identificados foram: deslocamento da agulha em punções de FAV, infecções, disfunção do acesso, coagulação do sistema extracorpóreo e quedas. Sendo as ações para diminuição desses eventos: educação continuada, definição de diretrizes e políticas, adoção de ações não punitivas com incentivo a notificação dos eventos adversos, implementação de listas de tarefas e responsabilidades, checkList de verificação. A unidade de diálise é um ambiente propicio para o acontecimento de eventos adversos, necessitando assim, da fomentação de estratégias que identifiquem e previnam riscos.

show abstract

“…As a result, it can have significant preventive effects (bacteremia and sepsis) (5,11). According to some studies, in addition to superiority over heparin, it can be used in conjunction with antibiotics as well as antibiotics alone (12).…”

Section: Introductionmentioning

confidence: 99%

Taurolock versus saline 5% on preventing infection and dysfunction of hemodialysis catheters; a randomized, double blind controlled clinical trial

et al. 2020

View full text Add to dashboard Cite

Introduction: Despite the higher rate of morbidity and mortality, the use of central venous catheters has increased significantly compared to arteriovenous fistula. So far, no ideal organic solution has been identified for the prevention of thrombosis and catheter-related infection in patients undergoing hemodialysis. Objectives: This study aimed to evaluate the efficacy of Taurolock versus saline 5% on the prevention of catheter dysfunction and catheter-related infections. Patients and Methods: Seventy patients with chronic kidney disease, who requiring hemodialysis or those with permanent hemodialysis catheters referring to hemodialysis centers of Ahvaz, were selected and randomly divided into two groups, while 68 patients remained until the end of the study. In the first group, saline 5% was inserted into the lumen of catheter after each hemodialysis, and then catheter was blocked. In the second group, Taurolock solution (TauroLock™ -Hep 500®: Taurolidine; antimicrobial agent), citrate 4% and heparin (UI/mL) were used as antibiotics. Results: No significant difference between the catheter-related infection and positive blood culture in both saline and Taurolock groups was detected (2.94% versus 2.94%; P >0.05). Moreover, the catheter-related dysfunction in the saline 5% group was 5% less than the Taurolock group (2.94% versus 11.76%, P = 0.365). Conclusion: The results showed that saline 5% is at least as effective as a Taurolock solution for prevention of infections and catheter dysfunction. Saline is an effective, inexpensive, safe and readily available in various settings. Therefore, it could be considered as a proper alternative solution for reduction of dialysis-related side effects and costs. Trial Registration: Registration of trial protocol has been approved in Iranian registry of controlled trials (identifier: IRCT20190304042918N1; https://en.irct.ir/trial/38055, ethical code# IR.AJUMS.REC.1397.412).

show abstract

Comparação entre citrato trissódico e heparina como solução para selo de cateter em pacientes em hemodiálise

Cited by 7 publications

References 21 publications

Bloodstream infection in patients with end-stage renal disease in a teaching hospital in central-western Brazil

Bloodstream infection in patients with end-stage renal disease in a teaching hospital in central-western Brazil

Segurança do paciente em tratamento dialítico

Taurolock versus saline 5% on preventing infection and dysfunction of hemodialysis catheters; a randomized, double blind controlled clinical trial

Contact Info

Product

Resources

About